This HTML5 document contains 140 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.3109/
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37077188
rdf:type
wikibase:Item
schema:description
article scientific artigo científico (publicado na 2013) vedecký článok מאמר מדעי vetenskaplig artikel wetenschappelijk artikel videnskabelig artikel (udgivet 2013) мақолаи илмӣ article scientifique publié en 2013 2013年学术文章 2013年學術文章 bilimsel makale vědecký článek سائنسی مضمون научна статия vitskapeleg artikkel wissenschaftlicher Artikel articol științific mokslinis straipsnis 2013년 논문 article científic 2013年學術文章 2013年学术文章 2013 nî lūn-bûn scientific article published on 04 March 2013 مقالة علمية نشرت في 04 مارس 2013 artigo científico (publicado na 2013) artikulong pang-agham 2013年学术文章 ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2013年學術文章 2013年学术文章 مقالهٔ علمی tudományos cikk vitenskapelig artikkel επιστημονικό άρθρο наукова стаття, опублікована в березні 2013 scienca artikolo tieteellinen artikkeli articolo scientifico artículu científicu espublizáu en 2013 2013年の論文 2013年學術文章 научни чланак 2013年学术文章 научни чланак naučni članak บทความทางวิทยาศาสตร์ artykuł naukowy գիտական հոդված artikull shkencor სამეცნიერო სტატია 2013年學術文章 научная статья artículo científico publicado en 2013 artigo científico мақолаи илмӣ 2013年學術文章 teaduslik artikkel bài báo khoa học
p:P577
wds:Q37077188-B2F7926B-B590-4BE3-A31D-D7E87DAEFDEF
wdt:P577
2013-03-04T00:00:00Z
p:P2860
wds:Q37077188-B3C1E123-F07E-449F-8AA1-279B83621677 wds:Q37077188-FE194821-D652-4DFC-B739-E98F4147C0A7 wds:Q37077188-7C90C6C1-FD2A-4DCF-B777-D1F49E3FC2F0 wds:Q37077188-81E83F1F-5D56-4A43-A27D-C9A53530485F wds:Q37077188-05131611-15A1-411B-B8F9-67BE7A334C7A wds:Q37077188-1000536C-ABAE-4273-B0D9-0D48BECBA8B5 wds:Q37077188-17BFE9BF-3E81-45E2-BF43-2A444CF06A1A wds:Q37077188-4C06C105-4D95-4266-9331-366DB59EF4AE wds:Q37077188-54D95B04-F82A-43C1-A812-077EE505AF4D wds:Q37077188-5906D26D-2846-4344-971D-9FEEC662FD9C wds:Q37077188-66C2DE85-D0E6-4AE7-9360-C0C30B265CB6 wds:Q37077188-182D9E08-BB86-4DF0-965F-AF14D1AD99C6 wds:Q37077188-19BDE301-F33F-46BA-9792-25B94A0F7D0B wds:Q37077188-1DD1D89E-4EB4-4CF7-92E3-05B046418073 wds:Q37077188-2EC71828-D49B-408B-BE7A-5BCCC626FB76 wds:Q37077188-369A7D17-7177-4D36-80DD-AA2E23F4022E wds:Q37077188-38085DE3-19B7-497D-88FC-4247593B2B2E
wdt:P2860
wd:Q47281499 wd:Q41086292 wd:Q33380059 wd:Q70989168 wd:Q37243800 wd:Q46465804 wd:Q33508936 wd:Q35224749 wd:Q42631263 wd:Q53137731 wd:Q47306075 wd:Q33489438 wd:Q44750497 wd:Q47281487 wd:Q34573761 wd:Q47281516 wd:Q40544848
p:P2093
wds:Q37077188-51795E6D-A091-412C-81C5-5E172F50EFBD wds:Q37077188-33208BAF-6AA6-47D0-868B-55C58979EA09 wds:Q37077188-DFD03175-E0DA-423B-9F43-E1334C717C61 wds:Q37077188-FA80E3B9-8024-4754-AC32-E686537D2946 wds:Q37077188-C1170D1D-A5A1-418D-AC37-ADED1AD28C70 wds:Q37077188-8E80D5E1-273A-4683-BE37-5AD84AD160BC wds:Q37077188-873B11E2-2F51-4ADB-A965-3294237F86E8
wdt:P2093
M R Betha C Gadiko S K Tippabhotla S Thota M Nakkawar V Vobalaboina R Cheerla
rdfs:label
Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers
skos:prefLabel
Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers
schema:name
Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers
p:P1476
wds:Q37077188-78852EEE-1DE0-48D0-AC4D-56AE03489703
wdt:P1476
Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers
p:P304
wds:Q37077188-6F465CCC-26F5-45D1-8AC3-19CDB93282EF
wdt:P304
21-29
p:P31
wds:Q37077188-15F67019-3178-4275-A409-F64B1C3F5622
wdt:P31
wd:Q13442814
p:P698
wds:Q37077188-3ACB3E66-E565-414A-8037-25AD0803BA70
wdtn:P698
n9:27536434
wdt:P698
27536434
p:P1433
wds:Q37077188-0BDB1DA4-83F5-441B-812E-20AD55F565FD
wdt:P1433
wd:Q27727198
p:P433
wds:Q37077188-59DF4994-B851-4531-98C8-77B03D5EAA6A
p:P478
wds:Q37077188-4E12664C-DEBC-4A9A-8C5F-45444E5585D6
wdt:P433
1
wdt:P478
2
p:P356
wds:Q37077188-74C80E7E-31F5-450F-91DF-03E066B610DA
wdtn:P356
n12:21556660.2013.781504
wdt:P356
10.3109/21556660.2013.781504
p:P932
wds:Q37077188-62457195-4911-48CA-BD2D-A71497977FA4
wdt:P932
4937650